2014
DOI: 10.1016/j.ijpharm.2014.05.057
|View full text |Cite
|
Sign up to set email alerts
|

Preclinical evaluation of thermoreversible triamcinolone acetonide hydrogels for drug delivery to the inner ear

Abstract: Graphical abstract

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
17
0

Year Published

2015
2015
2024
2024

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 40 publications
(17 citation statements)
references
References 22 publications
0
17
0
Order By: Relevance
“…The thermoreversible 20% w/v poloxamer 407 hydrogel (BASF SE, Ludwigshafen, Germany) was prepared using the cold-method and loaded with 6% dexamethasone (Gatt-Koller, Absam, Austria) or 30% triamcinolone-acetonide (Fagron, Barsbüttel, Germany), as previously described [13].…”
Section: Methodsmentioning
confidence: 99%
“…The thermoreversible 20% w/v poloxamer 407 hydrogel (BASF SE, Ludwigshafen, Germany) was prepared using the cold-method and loaded with 6% dexamethasone (Gatt-Koller, Absam, Austria) or 30% triamcinolone-acetonide (Fagron, Barsbüttel, Germany), as previously described [13].…”
Section: Methodsmentioning
confidence: 99%
“…Another advantage of using poloxamers is the ability to deliver low solubility therapeutics. Formation of micelles in the hydrogel facilitates loading of hydrophobic drugs and gel formation (Engleder et al, 2014). Low solubility drugs such as dexamethasone and methylprednisolone are more easily incorporated in the poloxamer hydrogel compared to aqueous solution (Wang et al, 2011).…”
Section: Biomaterials For Local Drug Deliverymentioning
confidence: 99%
“…The main approaches for local delivery of glucocorticoids into the inner ear are based on injection of polymeric hydrogels onto the round window [16]. Thermoresponsive in situ forming hydrogel containing 20% Poloxamer 407 (Pluronic F127) and 30% triamcinolone acetonide has been recently developed for prolonged intratympanic release of the drug [18].…”
Section: Accepted Manuscriptmentioning
confidence: 99%